Marksans Pharma Ltd Board of Directors

Home

Insights

Board of Directors

₹ 11.9 Cr

Volume transacted

434.7 K

stocks traded

Last Updated time: 19 Sep 9.00 AM

Board of Directors

Name	Designation

Mark Saldanha	Chairman & Managing Director
Harshavardhan Panigrahi	Company Sec. & Compli. Officer
Seetharama Raju Buddharaju	Non-Exec. & Independent Dir.
Sandra Saldanha	Whole-time Director
Digant Mahesh Parikh	Non-Exec. & Independent Dir.

name	designation
Mark Saldanha	Chairman & Managing Director
Harshavardhan Panigrahi	Company Sec. & Compli. Officer
Seetharama Raju Buddharaju	Non-Exec. & Independent Dir.
Sandra Saldanha	Whole-time Director
Digant Mahesh Parikh	Non-Exec. & Independent Dir.

Open Demat Account

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Key Highlights

Mark Saldanha continues to serve as the Chairman & Managing Director in 2024, maintaining the same position as in the previous year.
Harshavardhan Panigrahi continues to serve as the Company Sec. & Compli. Officer in 2024, maintaining the same position as in the previous year.
Seetharama Raju Buddharaju continues to serve as the Non-Exec. & Independent Dir. in 2024, maintaining the same position as in the previous year.
Sandra Saldanha continues to serve as the Whole-time Director in 2024, maintaining the same position as in the previous year.
Digant Mahesh Parikh continues to serve as the Non-Exec. & Independent Dir. in 2024, maintaining the same position as in the previous year.

Marksans Pharma Ltd

NSE: MARKSANS

PRICE

Last updated:

Last Ten Days Share Price

Date	Price	Day Open	Day High	Day Low

19 Sep 2024	274.25	282.7	289	271.85
18 Sep 2024	281.25	296	298.7	277.2
17 Sep 2024	296.25	294.65	297.95	284.95
16 Sep 2024	293.85	281.95	296.8	280
13 Sep 2024	277.35	270.25	284.3	268.5
12 Sep 2024	268.1	274.25	274.95	266.85
11 Sep 2024	272.85	265.3	276	261.1
10 Sep 2024	263.5	262.7	273.15	259.3
09 Sep 2024	258.5	266.45	266.45	255.5
06 Sep 2024	263	267.95	278.4	261.8

Date	Price
19 Sep 2024	274.25
18 Sep 2024	281.25
17 Sep 2024	296.25
16 Sep 2024	293.85
13 Sep 2024	277.35
12 Sep 2024	268.1
11 Sep 2024	272.85
10 Sep 2024	263.5
09 Sep 2024	258.5
06 Sep 2024	263

Company Fundamentals for Marksans Pharma Ltd

Market Cap

₹ 12,428 Cr

EPS

₹ 7.4

P/E Ratio (TTM) *

37.2

P/B Ratio (TTM) *

6.0

Day’s High *

289.0

Day’s Low

₹ 271.85

DTE *

0.1

ROE *

15.2

52 Week High

₹ 298.7

52 Week Low

₹ 97.6

ROCE *

18.8

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

Monitoring Marksans Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Marksans Pharma Ltd News Hub

Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules

Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketin...

21 Aug 202420:00

Marksans Pharma's Verna unit successfully completes USFDA inspection

Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR...

20 Aug 202414:37

Marksans Pharma to convene AGM

Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be hel...

20 Aug 202410:46

Marksans Pharma gets EIR from USFDA for Goa facility

The inspection has been classified as voluntary action indicated (VAI) and has been closed...

20 Aug 202414:48

Marksans Pharma surges after Q1 PAT rises 29% YoY to Rs 89 cr

Revenue from operations jumped 18.12% YoY to Rs 590.62 crore in first quarter of FY25, dri...

14 Aug 202412:04

Marksans announces receipt of marketing authorization for Levonorgestrel 1.5 mg Tablets

Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketin...

02 Aug 202416:12

Document

Annual Reports

N/A

Credit Ratings

N/A

Concalls

Marksans Pharma Ltd market cap

Marksans Pharma Ltd share price history

Marksans Pharma Ltd isin code

Sun Pharmaceuticals Industries Ltd board of directors

Divis Laboratories Ltd board of directors

Cipla Ltd board of directors

Torrent Pharmaceuticals Ltd board of directors

Dr Reddys Laboratories Ltd board of directors

Zydus Lifesciences Ltd board of directors

Lupin Ltd board of directors

Mankind Pharma Ltd board of directors

Aurobindo Pharma Ltd board of directors

Alkem Laboratories Ltd board of directors

FAQs for Board of Directors of Marksans Pharma Ltd

How are members of Marksans Pharma Ltd Board of Directors selected?

Members of the Marksans Pharma Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Marksans Pharma Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the Marksans Pharma Ltd Board of Directors?

Shareholders can interact with the Marksans Pharma Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the Marksans Pharma Ltd Board of Directors meet?

The Marksans Pharma Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the Marksans Pharma Ltd Board of Directors?

The Marksans Pharma Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at Marksans Pharma Ltd?

The current Board of Directors at Marksans Pharma Ltd includes Mark Saldanha( Chairman & Managing Director) ,Harshavardhan Panigrahi( Company Sec. & Compli. Officer) ,Seetharama Raju Buddharaju( Non-Exec. & Independent Dir.) ,Sandra Saldanha( Whole-time Director) ,Digant Mahesh Parikh( Non-Exec. & Independent Dir.) . The full list can be found on Marksans Pharma Ltd’s official website or recent corporate filings.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*

Marksans Pharma Ltd Board of Directors

Board of Directors

Key Highlights

Last Ten Days Share Price

Company Fundamentals for Marksans Pharma Ltd

PRICE

Share price Over Time

Marksans Pharma Ltd News Hub

Document

Popular Search